GP73, a novel TGF-β target gene, provides selective regulation on Smad and non-Smad signaling pathways

Xiaoli Yang,Congwen Wei,Ning Liu,Feixiang Wu,Jiankang Chen,Cui Wang,Zhenyu Sun,Yufei Wang,Liping Liu,Xiaoli Zhang,Beihan Wang,Yanhong Zhang,Hui Zhong,Yue Han,Xiang He

DOI: https://doi.org/10.1016/j.bbamcr.2019.01.001

Abstract:Increased GP73 expression in hepatocytes from patients with acute hepatitis, through disease progression to cirrhosis and chronic liver disease suggests that progressive tissue remodeling and fibrogenesis are driving forces for GP73 upregulation. Nevertheless, details about regulation of GP73 expression and its biological functions remain elusive and await further characterization. In this study, we demonstrate that GP73 is a direct target of TGF-β1 transcriptional regulation. Its induced expression inhibits TGF-β-Smad mediated growth suppression. On the other hand, elevated GP73 results in upregulation of ERK/Akt signaling induced by TGF-β1. Mechanistically, upregulation of lipid raft and caveolae-1 induced by GP73 overexpression mediates its regulatory effect on TGF-β1 signaling. Notably, lipid raft expression is elevated in HCC tumors and tissues with higher GP73 expression yield more intensive Flotillin staining. Our results establish the linkage between GP73 and TGF-β signaling, indicating that GP73 may promote HCC tumorigenesis by selectively regulating TGF-β signaling through lipid raft modulation.